Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 84

1.

Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase that favorably modulates lipid mediator biosynthesis in inflammation.

Cheung SY, Werner M, Esposito L, Troisi F, Cantone V, Liening S, König S, Gerstmeier J, Koeberle A, Bilancia R, Rizza R, Rossi A, Roviezzo F, Temml V, Schuster D, Stuppner H, Schubert-Zsilavecz M, Werz O, Hanke T, Pace S.

Eur J Med Chem. 2018 Aug 5;156:815-830. doi: 10.1016/j.ejmech.2018.07.031. Epub 2018 Jul 25.

PMID:
30053720
2.

[CRISPR/Cas9 SAM (synergic activation mediator): a new strategy to screen for genome-encoded antiviral restriction factors].

Dekeyzer B, Hoareau M, Laghlali G.

Med Sci (Paris). 2018 May;34(5):401-403. doi: 10.1051/medsci/20183405010. Epub 2018 Jun 13. French. No abstract available.

3.

Features of borderline personality disorder as a mediator of the relation between childhood traumatic experiences and psychosis-like experiences in patients with mood disorder.

Baryshnikov I, Aaltonen K, Suvisaari J, Koivisto M, Heikkinen M, Joffe G, Isometsä E.

Eur Psychiatry. 2018 Mar;49:9-15. doi: 10.1016/j.eurpsy.2017.12.005. Epub 2018 Jan 30.

PMID:
29353179
4.

Structural features of the interaction of the 3'-untranslated region of mRNA containing exosomal RNA-specific motifs with YB-1, a potential mediator of mRNA sorting.

Yanshina DD, Kossinova OA, Gopanenko AV, Krasheninina OA, Malygin AA, Venyaminova AG, Karpova GG.

Biochimie. 2018 Jan;144:134-143. doi: 10.1016/j.biochi.2017.11.007. Epub 2017 Nov 11.

PMID:
29133115
5.

Therapeutic potential of Mediator complex subunits in metabolic diseases.

Ranjan A, Ansari SA.

Biochimie. 2018 Jan;144:41-49. doi: 10.1016/j.biochi.2017.10.012. Epub 2017 Oct 20. Review.

PMID:
29061530
6.

Coping as a mediator of stress and psychotic-like experiences.

Ered A, Gibson LE, Maxwell SD, Cooper S, Ellman LM.

Eur Psychiatry. 2017 Jun;43:9-13. doi: 10.1016/j.eurpsy.2017.01.327. Epub 2017 Feb 9.

7.

Benfluorex: adverse effects reviewed, 1976-2015.

[No authors listed]

Prescrire Int. 2017 Feb;26(179):47. No abstract available.

PMID:
30726634
8.

[Drug-induced valve heart disease].

Tribouilloy C, Jobic Y.

Rev Prat. 2016 Oct;66(8):874-880. French.

PMID:
30512542
9.

Cyberpharmacovigilance: What is the usefulness of the social networks in pharmacovigilance?

Bagheri H, Lacroix I, Guitton E, Damase-Michel C, Montastruc JL.

Therapie. 2016 Apr;71(2):235-9. doi: 10.1016/j.therap.2015.09.002. Epub 2016 Mar 28. English, French.

PMID:
27080844
10.

Interferon gamma effect on immune mediator production in human nerve cells infected by two strains of Toxoplasma gondii.

Mammari N, Vignoles P, Halabi MA, Dardé ML, Courtioux B.

Parasite. 2015;22:39. doi: 10.1051/parasite/2015039. Epub 2015 Dec 21.

11.

[Video games, a therapeutic mediator for teens].

Nickler C.

Rev Infirm. 2015 Oct;(214):35-6. doi: 10.1016/j.revinf.2015.06.012. French.

PMID:
26455625
12.

[From ergot of rye to Mediator].

Choisy H, Ségal A.

Hist Sci Med. 2014 Oct-Dec;48(4):537-9. French. No abstract available.

PMID:
25962221
13.

European pharmacovigilance: increasingly outsourced to drug companies.

[No authors listed]

Prescrire Int. 2014 Dec;23(155):302-3, 305-7.

PMID:
25629153
14.

Self-stigma as a mediator between social capital and empowerment among people with major depressive disorder in Europe: the ASPEN study.

Lanfredi M, Zoppei S, Ferrari C, Bonetto C, Van Bortel T, Thornicroft G, Knifton L, Quinn N, Rossi G, Lasalvia A; ASPEN Study group.

Eur Psychiatry. 2015 Jan;30(1):58-64. doi: 10.1016/j.eurpsy.2014.06.002. Epub 2014 Aug 29.

15.

Benfluorex: left heart valve disease very common.

[No authors listed]

Prescrire Int. 2014 May;23(149):128. No abstract available.

PMID:
24926516
16.

Tau acts as a mediator for Alzheimer's disease-related synaptic deficits.

Liao D, Miller EC, Teravskis PJ.

Eur J Neurosci. 2014 Apr;39(7):1202-13. doi: 10.1111/ejn.12504. Review.

17.

Identifying drug-related disorders: a probabilistic approach.

[No authors listed]

Prescrire Int. 2013 Dec;22(144):293. No abstract available.

PMID:
24600730
18.

Drug-related cardiac valve disease.

[No authors listed]

Prescrire Int. 2013 Dec;22(144):292-5. Review.

PMID:
24600729
19.

Drugs induced pulmonary arterial hypertension.

Seferian A, Chaumais MC, Savale L, Günther S, Tubert-Bitter P, Humbert M, Montani D.

Presse Med. 2013 Sep;42(9 Pt 2):e303-10. doi: 10.1016/j.lpm.2013.07.005. Epub 2013 Aug 22. Review.

PMID:
23972547
20.

Exposure to benfluorex: left heart valve disease very common.

[No authors listed]

Prescrire Int. 2013 Jul;22(140):185. No abstract available.

PMID:
23951595

Supplemental Content

Loading ...
Support Center